CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Andy P

    Andy P’s Immunotherapy Story

    Prostate Cancer |  Diagnosed 2014 Immunotherapy is a new and lasting treatment for cancer. Andy’s Story Faced with…
    May 22, 2018| CRI Staff
  • Going “Through the Kitchen” to Cure Cancer

    Cancer Research Institute held its annual Through the Kitchen benefit party yesterday evening and raised $1.4 million to…

    May 7, 2018| Marla Lawson
  • Second CAR T Cell Immunotherapy Approved for Patients with Lymphoma

    A second CAR T cell immunotherapy targeting the CD19 receptor was approved by the FDA for patients…

    May 3, 2018| Arthur N. Brodsky, PhD
  • The Art of Transformation at CRI’s 2018 Through the Kitchen Party

    On May 6, 2018, Through the Kitchen Party guests and others have the opportunity to bid on…

    May 2, 2018| Diana Denza
  • The Power of Transformational Gifts

    Atlantic Philanthropies, a large charitable foundation, recently released a report summarizing the group's investments in cancer and…

    May 1, 2018| Marla Lawson
  • Advocating for Innovative Clinical Trial Design

    Laura Pearce, CRI consultant and head of clinical alliances, participates in a clinical trials panel on platform…

    April 25, 2018| Katherine McCluskey
  • AACR18 Recap: Immunotherapy in the Spotlight

    Immunotherapy took center stage and dominated the headlines at AACR18.

    April 23, 2018| Arthur N. Brodsky, PhD
  • AACR18 Update: Lloyd J. Old Award, Overcoming Immunotherapy Resistance, and the Importance of Dendritic Cells

    Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and…

    April 18, 2018| Arthur N. Brodsky, PhD
  • AACR18 Day 3 Update: Lung Cancer in the Spotlight, Immune Memory, and New Immunotherapy Biomarkers

    Day 3 of AACR18 highlighted potentially “practice-changing” immunotherapy breakthroughs in lung cancer, and insights into the factors…

    April 17, 2018| Arthur N. Brodsky, PhD
Previous Page
1 … 53 54 55 56 57 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute